ATG9B anticorps (AA 110-121) (Biotin)
Aperçu rapide pour ATG9B anticorps (AA 110-121) (Biotin) (ABIN5066220)
Antigène
Voir toutes ATG9B AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 110-121
-
Specificité
- Highly expressed in placenta (trophoblast cells) and pituitary gland. Not expressed in vascular endothelial.,Detects ~100 kDa.
-
Réactivité croisée
- Humain, Souris
-
Purification
- Peptide Affinity Purified
-
Immunogène
- Synthetic peptide from the N-terminal of Human ATG9B (aa. 110-121)
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
- WB (1:1000)
- ICC/IF (1:100)
- optimal dilutions for assays should be determined by the user.
-
Commentaires
-
A 1:1000 dilution of ABIN5066220 was sufficient for detection of ATG9B in 15 μg of Human HeLa Cell Lysates by ECL immunoblot analysis using goat anti-rabbit IgG:HRP as the secondary antibody.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, 50 % glycerol, 0.09 % sodium azide, Storage buffer may change when conjugated
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Conjugated antibodies should be stored at 4°C
-
-
- ATG9B (Autophagy Related 9B (ATG9B))
-
Autre désignation
- ATG9B
-
Sujet
- ATG9B is involved in autophagy and cytoplasm to vacuole transport (Cvt) vesicle formation. Plays a key role in the organization of the preautophagosomal structure/phagophore assembly site (PAS), the nucleating site for formation of the sequestering vesicle. Highly expressed in the placenta and the pituitary gland.
-
ID gène
- 285973
-
NCBI Accession
- NP_001303985
-
UniProt
- Q674R7
Antigène
-